<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="51889">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01826630</url>
  </required_header>
  <id_info>
    <org_study_id>CLN 2012H0327</org_study_id>
    <nct_id>NCT01826630</nct_id>
  </id_info>
  <brief_title>A Study to Assess CLnÂ® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema</brief_title>
  <official_title>A Double-Blind Pilot Study To Assess The Feasibility of a Larger Study to Assess The Efficacy of A Novel Gel Wash Cleanser Formulated With Sodium Hypochlorite To Reduce Skin Fauna In Patients With Chronic Hand Dermatitis/Atopic Dermatitis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shari L Hand</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>TopMD Skin Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>TopMD Skin Care, Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this protocol is to acquire pilot data for a larger study to test
      the following hypothesis: Treatment of the hands of patients with chronic hand
      dermatitis/atopic dermatitis with CLn BodyWash, a novel gel wash cleanser currently marketed
      as a cosmetic product containing a dilute concentration of less than 0.01% sodium
      hypochlorite and less than 0.005% concentration as it is lathered, will result in a
      statistically significant reduction in the number of skin fauna present on the hands of
      these patients compared to treatment of such patients with traditional wash used clinically
      such as Cetaphil Daily Facial Cleanser.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with Hand Eczema will be asked to wash with either a CLn BodyWash or Cetaphil Daily
      Facial Cleanser.  Patients and study staff will be blinded.  Hand swabs will be done prior
      to the wash and after 20 minutes.  The average time spent in the study for each patient
      should be less than 2 hours unless an Adverse Event occurs.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Change in Amount of Skin Fauna</measure>
    <time_frame>one wash</time_frame>
    <safety_issue>No</safety_issue>
    <description>Mean Decrease in Fauna after Washing with either CLn BodyWash or Cetaphil Daily Facial Cleanser.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Eczema</condition>
  <condition>Hand Eczema</condition>
  <condition>Atopic Dermatitis</condition>
  <arm_group>
    <arm_group_label>CLn BodyWash</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CLn BodyWash will be used to wash hands of patients with Hand Atopic Dermatitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cetaphil Daily Facial Cleanser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cetaphil Daily Facial Cleanser will be used to wash hands of patients with Hand Atopic Dermatitis</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CLn BodyWash</intervention_name>
    <description>Comparing two washes to determine change in bacterial load.</description>
    <arm_group_label>CLn BodyWash</arm_group_label>
    <other_name>CLn BodyWash</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cetaphil Daily Facial Cleanser</intervention_name>
    <description>Comparing two washes to determine change in bacterial load.</description>
    <arm_group_label>Cetaphil Daily Facial Cleanser</arm_group_label>
    <other_name>Cetaphil Daily Facial</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Seen by an OSU Dermatology provider at OSU Dermatology East after the date of
             approval of this protocol

          -  Ability to provide informed consent, or parent or legal guardian capable of providing
             consent for child or mentally handicapped individuals

          -  Willingness to participate in a research study.

          -  Diagnosis of chronic hand dermatitis

        Exclusion Criteria:

          -  Inability to provide informed consent

          -  Allergy to any of the treatments used
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Derek V. Chan, MD, PhD</last_name>
    <phone>614.293.1707</phone>
    <email>derek.chan@osumc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Gahanna</city>
        <state>Ohio</state>
        <zip>43230</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Derek V. Chan, MD, PhD</last_name>
      <phone>614-293-1707</phone>
      <email>derek.chan@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Matthew Zirwas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 13, 2013</lastchanged_date>
  <firstreceived_date>February 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>TopMD Skin Care, Inc.</investigator_affiliation>
    <investigator_full_name>Shari L Hand</investigator_full_name>
    <investigator_title>Clinical Research Director</investigator_title>
  </responsible_party>
  <keyword>CLn Body Wash</keyword>
  <keyword>CLn BodyWash</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Atopic</mesh_term>
    <mesh_term>Eczema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
